Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 2,085.00
+20.00 (0.97%)
Jul 1, 2026, 3:30 PM KST
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 27.2 billion as of July 1, 2026. Its market cap has decreased by -79.42% in one year.
Market Cap
27.20B
Enterprise Value
273.41B
Revenue
78.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,085.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 27.20B, an increase of 756.04%. That is a compound annual growth rate of 7.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 27.20B | -73.47% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyongbo Pharmaceutical | 118.22B |
| AptaBio Therapeutics | 112.37B |
| Jeil Pharma Holdings | 96.56B |
| HANDOK | 87.04B |
| Enzychem Lifesciences | 76.86B |
| CKD Bio | 68.19B |
| Kukje Pharma | 64.65B |
| Ildong Holdings | 64.48B |